EUVIMEDEUVIMED entdecken
Crossref

Dose optimization of vancomycin in critically ill pediatric patients: A population pharmacokinetic study

Pham Thu Ha, Nguyen Thi Cuc, Hoang Hai Linh, Tran Nhat Minh, Nguyen Viet Anh, Le Thi Nguyet Minh, Tran Thi Hanh Nguyen, Nguyen Lan Huong, Nguyen Thi Hong Ha, Tran Minh Dien, Vu Dinh Hoa

Tạp chí Nghiên cứu Dược và Thông tin Thuốc · 05.11.2026 · 33

DOI: 10.59882/1859-364x/477 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Tạp chí Nghiên cứu Dược và Thông tin Thuốc, online erschienen am 05.11.2026. Verfasst von Pham Thu Ha und 10 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vancomycin has been the first-line therapy for treatment of severe Gram-positive infections in critically ill pediatric patients; however, high inter- and intra-individual variability on pharmacokinetics posed significant challenges in selecting the optimal dose. This study aimed to develop a population pharmacokinetic (popPK) model for vancomycin in critically ill pediatric patients and optimize the initial dose based on this model. Therapeutics drug monitoring (TDM) data was collected retrospectively from 245 patients receiving intravenous vancomycin at the Pediatric Intensive Care Unit (PICU), Vietnam National Children’s Hospital. Population pharmacokinetics modeling and Monte Carlo simulation were performed with the AUC target of 400–800 mg×h/L to optimize efficacy and minimize toxicity with the help of NONMEM®7.5.1. The results showed that a two-compartment model, allometric scaling by weight with first-order elimination and combined additive and proportional error best fitted data. Typical values of central and peripheral volumes of distribution were 0.180 and 0.297 L/kg, respectively. Typical clearance of 0.260 was predicted by body weight, serum creatinine (SCr), and postmenstrual age. The optimal doses adjusted by age and SCr to achieve PTA range from 25–60 mg/kg per day for infants < 3 months, 30–75 mg/kg per day for 3 months to 1 year, and 40–80 mg/kg per day for children ≥ 1 year with SCr of >80, 40–80, 20–40, and

Zitieren

APA

Ha, P. T., Cuc, N. T., Linh, H. H., Minh, T. N., Anh, N. V., Minh, L. T. N., Nguyen, T. T. H., Huong, N. L., Ha, N. T. H., Dien, T. M., & Hoa, V. D. (2026). Dose optimization of vancomycin in critically ill pediatric patients: A population pharmacokinetic study. Tạp chí Nghiên cứu Dược và Thông tin Thuốc, 33. https://doi.org/10.59882/1859-364x/477

Vancouver

Ha PT, Cuc NT, Linh HH, Minh TN, Anh NV, Minh LTN, et al. Dose optimization of vancomycin in critically ill pediatric patients: A population pharmacokinetic study. Tạp chí Nghiên cứu Dược và Thông tin Thuốc. 2026;33. doi:10.59882/1859-364x/477

BibTeX
@article{Ha2026,
  author = {Ha, Pham Thu and Cuc, Nguyen Thi and Linh, Hoang Hai and Minh, Tran Nhat and Anh, Nguyen Viet and Minh, Le Thi Nguyet and Nguyen, Tran Thi Hanh and Huong, Nguyen Lan and Ha, Nguyen Thi Hong and Dien, Tran Minh and Hoa, Vu Dinh},
  title = {Dose optimization of vancomycin in critically ill pediatric patients: A population pharmacokinetic study},
  journal = {Tạp chí Nghiên cứu Dược và Thông tin Thuốc},
  year = {2026},
  volume = {33},
  doi = {10.59882/1859-364x/477}
}
Kostenlos starten →